Author:
Tamatsukuri Tatsuro,Ohbayashi Masayuki,Kohyama Noriko,Kobayashi Yasuna,Yamamoto Toshinori,Fukuda Kenichiro,Nakamura Shunsuke,Miyake Yasufumi,Dohi Kenji,Kogo Mari
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference29 articles.
1. Ministry of Health, Labour and welfare. Demographics survey in Japan, http://www.mhlw.go.jp/toukei/list/81-1a.html [accessed 22 December 2017].
2. FDA. Drugs@FDA: FDA Approved Drug Products, https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050706 [accessed 26 December 2017].
3. The pharmacology of meropenem, a new carbapenem antibiotic;Craig;Clin Infect Dis,1997
4. Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates of human renal transporters;Shibayama;Drug Metab Pharmacokinet,2007
5. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations;Udy;Crit Care Med,2014
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献